Mercator snags FDA patent for blood-pressure drug delivery catheters

Mercator's micro-infusion catheters pulled in FDA patent protection.--Courtesy of Mercator

Mercator MedSystems pulled in a new FDA patent for its micro-infusion drug delivery devices for renal denervation and carotid body modulation procedures as a treatment for high blood pressure. This includes its Bullfrog catheter, which received a CE mark in Europe in March. Mercator recently completed a clinical feasibility study of the device in Germany to determine the effectiveness of lidocaine delivery to alleviate pain experienced during the procedures. The company reported "promising results" in four patients treated prior to energy-based renal denervation. Release